The vendor could prove a significant competitor in the AI notetaking space, given Epic’s leading market share in electronic health records.
Epic rolls out AI charting tool as scribe market heats up Read More »
Bristol Myers Squibb delivered better than expected fourth quarter earnings, but Eliquis missed expectations while Cobenfy continues to struggle with uptake.
BMS Beats Again Despite Eliquis and Cobenfy Disappointments Read More »
Novo Nordisk and Eli Lilly have been battling head-to-head in an exploding obesity market. They should never have been compared apples to apples.
Novo Will Never Beat Lilly. Why Does It Have To? Read More »
The 510(k) decision clears the device for use with ultra-rapid-acting insulins from Eli Lilly and Novo Nordisk.
Medtronic wins expanded FDA label for 780G insulin pump Read More »
Visit volume for physicians who scaled back on appointments declined nearly 33%, but their EHR time only fell 21%, according to a study published in Health Affairs.
Primary care physicians’ EHR work persists after reducing patient visits: study Read More »
Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year.
Eikon Clocks Largest IPO Since 2024, Generate Follows as IPO Tap Opens Read More »
En una investigación basada en escaneos de cuerpo entero por tomografía computerizada a momias, se han averiguado detalles reveladores acerca de dos hombres del Antiguo Egipto que fallecieron hace dos milenios. Entre los datos descubiertos figuran la edad aproximada que cada uno ten&ia …
Un nuevo estudio demuestra por vez primera que una tormenta de polvo anómala e intensa de escala local fue capaz de impulsar el transporte de agua hasta las capas más altas de la atmósfera marciana durante un verano del hemisferio norte del planeta, estación en la que est …
El cáncer es una de las mayores causas de muerte en el mundo. En 2020, por ejemplo, se cobró alrededor de diez millones de vidas. Se estima que entre el 13 y el 18% de esos casos fueron provocados por infecciones microbianas. Hasta el momento, la Agencia Internacional para la Investiga …
Descubren que un hongo que reside en nuestro cuerpo añade agresividad a un cáncer Read More »
One of the assets shelved by Eli Lilly is a gene therapy for dementia, which it obtained in its $1.04-billion acquisition of Prevail Therapeutics in late 2020.
Lilly Axes Three Therapies Amid Pipeline-in-a-Product Push for GLP-1 Read More »
